Using Red Wine to Coat Stents and Balloons | Interview with John Foley of Requisite Biomedical

Is red wine the next breakthrough therapy in the world of drug-eluting stents and balloons? The research looks promising, according to Dr. John Foley, cofounder of Requisite Biomedical.Requisite Biomedical was founded in 2009 to develop intravascular medical device coatings containing a combination of the natural compounds found in red wine – [...]

[Read more of this report]


ReQuisite Biomedical’s Ohio relocation plans hit a snag

When we last checked in with ReQuisite Biomedical, the Minnesota startup that’s developing a novel coating for stents and balloons was plotting a move to Ohio.More than a year later, the move is still squarely in the planning stages, co-founder John Foley said. But recently released promising preclinical data has Foley hoping that ReQuisite can [...]

[Read more of this report]


Coming to Northeast Ohio? Minnesota start-up ReQuisite Biomedical looking to attract funding for possible relocation

Armed with a $100,000 grant from Lorain County Community College’s Innovation Fund, ReQuisite Biomedical would like to raise another $800,000 before relocating, said co-founder and Chief Executive John Foley.

[Read more of this report]


Case Western Reserve, UH Case Medical Center part of consortium using $16 million to study anemia in the elderly ’ MedCity Evening Read, Dec. 16, 2009

Case Western Reserve University and University Hospitals Case Medical Center will participate in a consortium of national experts investigating why unexplained anemia is common in older adults. The consortium, called the Partnership for Anemia: Clinical and Translational Trials in the Elderly, is the result of a $16 million grant awarded by the National Institute on Aging.

[Read more of this report]


Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Twitter Buzz

MedCity Jobs Board

Real Time Web Analytics